Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Eileen Francis
Amazon’s Solimo supplements and personal care line overall is priced higher than Walgreens' brand but lower than CVS', Jefferies Equity Research Americas found. Solimo could present a formidable threat to the supplements category, but its limited assortment so far and pricing should prevent “material market share shifts” in the near-term, Jefferies says.
Amazon's Basic Care OTC brand SKUs have doubled units since last year's launch and is putting great pricing pressure on private label competitors, says a Jefferies analyst. But a private label consultant says the e-commerce giant's threat to competitors in the consumer health market is over-hyped.
UK's advertising regulator agrees that P&G's TV ads for Oral B Gum and Enamel Repair toothpaste were misleading. P&G argued ad claims that the product could fix enamel and reverse damage were cosmetic, not medicinal, because they only suggested the product could protect gums and promote overall oral health.
Racing Greens Nutraceuticals is advised to discontinue claims its energy and recovery supplement delivers “six of your five a day” daily servings of fruit and vegetables the UK recommends because it's a powder. Public Health England says fresh or frozen, canned, dried or juiced fruits and vegetables qualify, while a 150mL of unsweetened fruit juice, vegetable juice or a smoothie counts as a maximum of one portion of the five a day.
Products offered in online scams that lead to monthly bills usually are “something that the average person is going to be looking for, a renewal product like vitamins, tooth whitener and skin cream," says an FTC attorney. Federal judge halts sales by Triangle Media and associated companies and freezes their assets after FTC showed “immediate and irreparable injury, loss or damage” to consumers.
J&J agrees to sell marketing rights to its OTC 1% ketoconazole dandruff treatment product to Kramer Labs in the US and Latin America, to German firm Stada in the EMEA and to UK firm Alliance Pharma for the Asia-Pacific market as it continues to spin off non-core brands and focus on its core $1bn brands.